Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT05745285
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- LLS Program — OTHERThe intervention will be conducted virtually. Participants will receive LLS's free patient and caregiver services including co-pay assistance, transportation and urgent need assistance, a scholarship program for young adult patients and survivors, one-on-one peer-to-peer support, online chats and support groups facilitated by clinical social workers, and nutrition counseling with a registered dietician for 6 months.
Study Details
The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.
Key Dates
- Start date
- Feb 4, 2025
- Status verified
- Feb 2026
- Primary completion
- Oct 31, 2026
- Completion
- Nov 1, 2026
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: LLS Program and Usual Care GroupParticipants in the LLS Program and Usual Care condition will receive LLS services such as information, services, and financial aid so that patients can have better access to healthcare and better quality of life. Participants will also receive the standard care. Participants will be in this group for 6 months.
- No Intervention: Usual Care GroupParticipants will receive the standard care. Participants will be in this group for 6 months.
Primary Outcome Measure
Change in number of care needs as measured by the Access to Care Survey [ Time Frame: Baseline, 3 month, 6 month ]
Central Contacts
- Carlos Melara, MD3052438300
- Sara Fleszar-Pavlovic, PhD
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | Frank Penedo, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Chicago Comprehensive Cancer Center | Chicago | Illinois | 60637 | Mariam Nawas, MD (PRINCIPAL_INVESTIGATOR) |
| Mays Cancer Center at UT Health San Antonio | San Antonio | Texas | 78229 | Patricia Chalela, DrPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
By condition
By specialty
Related Studies
- Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)PHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALEPHASE1 · Recruiting · Baylor College of Medicine · Houston, Texas
- Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant SurvivorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado